Sign in

CIK 0001728328

  • Emerging growth company

Mentari Therapeutics, Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
981428279
Phone
+1 781-887-5080
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
InMed Pharmaceuticals Inc.
Open-market buys, last 90 days
$238,371
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$238K 10% owner 7 filings
Date Insider Transaction Shares Price Value Owned after
2022-11-14 Johnson Shane Aaron Sr VP & General Manager Returned to the company · Employee Stock Option (Right to Buy) −4,200 3,800
2022-11-14 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Returned to the company · Employee Stock Option (Right to Buy) −4,200 3,952
2022-11-14 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Returned to the company · Employee Stock Option (Right to Buy) −4,200 4,678
2022-11-14 ADAMS ERIC A President & CEO Returned to the company · Employee Stock Option (Right to Buy) −15,000 13,502
2022-11-14 WOUDENBERG MICHAEL Chief Operating Officer Returned to the company · Employee Stock Option (Right to Buy) −7,500 3,842
2022-11-14 Johnson Shane Aaron Sr. VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +4,200 8,000
2022-11-14 WOUDENBERG MICHAEL Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +7,500 11,342
2022-11-14 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Grant or award · Employee Stock Option (Right to Buy) +4,200 8,878
2022-11-14 ADAMS ERIC A President & CEO Grant or award · Employee Stock Option (Right to Buy) +15,000 28,502
2022-11-14 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Grant or award · Employee Stock Option (Right to Buy) +4,200 8,152
2022-08-10 Lemerond Nicole Director Grant or award · Employee Stock Option (Right to Buy) +14,000 14,000
2022-06-02 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −1,515 98,787
2022-06-02 ADAMS ERIC A President & CEO Other disposition · Employee Stock Option (Expiration) −13,636 337,576
2022-05-17 Baldasare Bryan T Director Grant or award · Employee Stock Option (Right to Buy) −14,000 14,000
2022-04-14 ADAMS ERIC A President & CEO Purchase +14,160 $0.89 $13K 59,003
2022-04-13 ADAMS ERIC A President & CEO Purchase +8,560 $0.85 $7K 44,843
2022-02-23 WOUDENBERG MICHAEL Grant or award · Employee Stock Option (Right to Buy) +5,000 96,060
2022-02-20 MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs Other disposition · Employee Stock Option (Expiration) −3,030 100,302
2022-02-18 Grove Janet P Director Grant or award · Employee Stock Option (Right to Buy) +14,000 14,000
2022-01-24 Garner William J Director Other disposition · Employee Stock Option (Expiration) −24,242 16,122

Page 7 of 9 · 173 trades